MedPath

The effect of premature chemotherapy termination in breast cancer on relapse

Conditions
C50.9
Breast, unspecified
Registration Number
DRKS00022566
Lead Sponsor
Ortenau-Klinikum Offenburg-Kehl
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1916
Inclusion Criteria

primary breast cancer, adjuvant chemotherapy recommended.

Exclusion Criteria

primary metastasis.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival and disease-free survival depending on premature termination of recommended chemotherapy for breast cancer.
Secondary Outcome Measures
NameTimeMethod
Subgroup analysis by age and type of tumor
© Copyright 2025. All Rights Reserved by MedPath